Related Experiment Video

Updated: Oct 3, 2026

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification
10:21

Primary Sjogren's Syndrome Associated with Lung Adenocarcinoma: Probing the Potential Common Pathogenic Mechanisms and Experimental Verification

Published on: September 20, 2024

The MKK6/p38 mitogen-activated protein kinase pathway is capable of inducing SOCS3 gene expression and inhibits

J G Bode1, S Ludwig, C A Freitas

  • 1Klinik für Gastroenterologie, Hepatologie und Infektiologie, Medizinische Klinik der Heinrich-Heine Universität, Düsseldorf, Germany.

Biological Chemistry
|December 1, 2001
PubMed

Insights

Interleukin-6 (IL-6) activates p38 mitogen-activated protein kinase (MAPK), which inhibits IL-6 signaling. This p38MAPK pathway is crucial for IL-6-induced suppressor of cytokine signaling 3 (SOCS3) expression.

Area of Science:

  • Cellular signaling pathways
  • Molecular biology
  • Immunology

Background:

  • Interleukin-6 (IL-6) is a key cytokine involved in immune responses and inflammation.
  • IL-6 signaling pathways regulate gene expression through various transcription factors, including STAT.
  • The role of specific MAPK pathways, like p38MAPK, in modulating IL-6 signaling requires further elucidation.

Purpose of the Study:

  • To investigate the role of the MKK6/p38MAPK pathway in IL-6-mediated signal transduction.
  • To determine the impact of p38MAPK activation on the transcriptional regulation of SOCS3 by IL-6.
  • To understand how p38MAPK activation influences other IL-6-mediated gene responses.

Main Methods:

  • Utilized p38MAPK-specific inhibitor SB202190 to assess its effect on SOCS3-mRNA expression.
  • Employed overexpression of constitutively active and dominant-negative MKK6 mutants in HepG2 cells.
  • Analyzed the transcriptional activation of a SOCS3 promoter reporter construct under various conditions.

Main Results:

  • p38MAPK activation by IL-6 acts as an inhibitory signal on STAT and alpha2-macroglobulin promoter activation.
  • Inhibition of p38MAPK with SB202190 downregulated IL-6-induced SOCS3-mRNA expression.
  • Overexpression of active MKK6 enhanced SOCS3 promoter activity, while dominant-negative MKK6 downregulated it.

Conclusions:

  • p38MAPK activation is essential for IL-6-induced expression of SOCS3.
  • The MKK6/p38MAPK pathway plays a critical role in the negative feedback regulation of IL-6 signaling.
  • These findings highlight a complex interplay between IL-6, p38MAPK, and SOCS3 in controlling cytokine responses.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...